Naturally inspired molecules as multifunctional agents for Alzheimer's disease treatment

Molecules

Volumn 21, Issue 5, 2016, Pages

  Rampa, Angela ^a   Tarozzi, Andrea ^a   Mancini, Francesca ^a   Pruccoli, Letizia ^a   Di Martino, Rita Maria Concetta ^a   Gobbi, Silvia ^a   Bisi, Alessandra ^a   De Simone, Angela ^a   Palomba, Francesco ^a   Zaccheroni, Nelsi ^a   Belluti, Federica ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

AD; BACE 1; Benzophenone; Chalcone; Metal chelation; Natural products; Reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; CHALCONE; CHELATING AGENT; DRUG COMBINATION; ION; LIGAND; METAL; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SECRETASE;

ALZHEIMER DISEASE; CHEMISTRY; DRUG COMBINATION; DRUG EFFECTS; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PROTEIN AGGREGATION, PATHOLOGICAL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; CHALCONE; CHELATING AGENTS; DRUG COMBINATIONS; HUMANS; IONS; LIGANDS; METALS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PROTEIN AGGREGATION, PATHOLOGICAL; REACTIVE OXYGEN SPECIES;

EID: 84973638018     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21050643     Document Type: Article

References (28)

1. Alzheimer's Association. Alzheimer's disease facts and figures. Alzheimers Dement. 2015, 11, 332-384.
2. Geldenhuys, W.J.; Youdim, M.B.; Carroll, R.T.; Van der Schyf, C.J. The emergence of designed multiple ligands for neurodegenerative disorders. Prog. Neurobiol. 2011, 94, 347-359.
3. Cavalli, A.; Bolognesi, M.L.; Minarini, A.; Rosini, M.; Tumiatti, V.; Recanatini, M.; Melchiorre, C. Multi-target-directed ligands to combat neurodegenerative diseases. J. Med. Chem. 2008, 51, 347-372.
4. Naslund, J.; Haroutunian, V.; Mohs, R.; Davis, K.L.; Davies, P.; Greengard, P.; Buxbaum, J.D. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 2000, 283, 1571-1577.
5. Hardy, J. Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal. J. Alzheimers Dis. 2006, 9, 151-153.
6. Yang, L.B.; Lindholm, K.; Yan, R.; Citron, M.; Xia, W.; Yang, X.L.; Beach, T.; Sue, L.; Wong, P.; Price, D.; et al. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 2003, 9, 3-4.
7. Silvestri, R. Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease. Med. Res. Rev. 2009, 29, 295-338.
8. Hong, L.; Koelsch, G.; Lin, X.; Wu, S.; Terzyan, S.; Ghosh, A.K.; Zhang, X.C.; Tang, J. Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor. Science 2000, 290, 150-153.
9. La Regina, G.; Piscitelli, F.; Silvestri, R. Synthetic strategies of nonpeptidic β-secretase (BACE1) inhibitors. J. Heter. Chem. 2009, 46, 10-17.
10. Rauk, A. The chemistry of Alzheimer's disease. Chem. Soc. Rev. 2009, 38, 2698-2715.
11. DeToma, A.S.; Choi, J.-S.; Braymer, J.J.; Lim, M.H. Myricetin: A Naturally Occurring Regulator of Metal-Induced Amyloid-β Aggregation and Neurotoxicity. Chembiochem 2011, 12, 1198-1201.
12. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66, 1022-1037.
13. Welsch, M.E.; Snyder, S.A.; Stockwell, B.R. Privileged scaffolds for library design and drug discovery. Curr. Opin. Chem. Biol. 2010, 14, 347-361.
14. Williams, R.J.; Spencer, J.P. Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic. Biol. Med. 2012, 52, 35-45.
15. Grazul, M.; Budzisz, E. Biological activity of metal ions complexes of chromones, coumarins and flavones. Coord. Chem. Rev. 2009, 253, 2588-2598.
16. Belluti, F.; Piazzi, L.; Bisi, A.; Gobbi, S.; Bartolini, M.; Cavalli, A.; Valenti, P.; Rampa, A. Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors. Eur. J. Med. Chem. 2009, 44, 1341-1348.
17. Belluti, F.; Bartolini, M.; Bottegoni, G.; Bisi, A.; Cavalli, A.; Andrisano, V.; Rampa, A. Benzophenone-based derivatives: A novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation. Eur. J. Med. Chem. 2011, 46, 1682-1693.
18. Belluti, F.; De Simone, A.; Tarozzi, A.; Bartolini, M.; Djemil, A.; Bisi, A.; Gobbi, S.; Montanari, S.; Cavalli, A.; Andrisano, V.; et al. Fluorinated benzophenone derivatives: Balanced multipotent agents for Alzheimer's disease. Eur. J. Med. Chem. 2014, 78, 157-166.
19. Morphy, R.; Kay, C.; Rankovic, Z. From magic bullets to designed multiple ligands. Drug Discov. Today 2004, 9, 641-651.
20. Belluti, F.; Rampa, A.; Piazzi, L.; Bisi, A.; Gobbi, S.; Bartolini, M.; Andrisano, V.; Cavalli, A.; Recanatini, M.; Valenti, P. Cholinesterase inhibitors: Xanthostigmine derivatives blocking the acetylcholinesterase-induced β-amyloid aggregation. J. Med. Chem. 2005, 48, 4444-4456.
21. Mancini, F.; De Simone, A.; Andrisano, V. β-Secretase as a target for Alzheimer's disease drug discovery: An overview of in vitro methods for characterization of inhibitors. Anal. Bioanal. Chem. 2011, 400, 1979-1996.
22. Stachel, S.J.; Coburn, C.A.; Steele, T.G.; Jones, K.G.; Loutzenhiser, E.F.; Gregro, A.R.; Rajapakse, H.A.; Lai, M.T.; Crouthamel, M.C.; Xu, M.; et al. Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1). J. Med. Chem. 2004, 47, 6447-6450.
23. De Vincenzo, R.; Ferlini, C.; Distefano, M.; Gaggini, C.; Riva, A.; Bombardelli, E.; Morazzoni, P.; Valenti, P.; Belluti, F.; Ranelletti, F.O.; et al. In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chemother. Pharmacol. 2000, 46, 305-312.
24. Tarozzi, A.; Marchesi, A.; Cantelli-Forti, G.; Hrelia, P. Cold-storage affects antioxidant properties of apples in caco-2 cells. J. Nutr. 2004, 134, 1105-1109.
25. Říha, M.; Karlíčková, J.; Filipský, T.; Macáková, K.; Hrdina, R.; Mladiěnka, P. Novel method for rapid copper chelation assessment confirmed low affinity of D-penicillamine for copper in comparison with trientine and 8-hydroxyquinolines. J. Inorg. Biochem. 2013, 123, 80-87.
26. Kim, D.O.; Lee, K.W.; Lee, H.J.; Lee, C.Y. Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals. J. Agric. Food Chem. 2002, 50, 3713-3717.
27. Tarozzi, A.; Bartolini, M.; Piazzi, L.; Valgimigli, L.; Amorati, R.; Bolondi, C.; Djemil, A.; Mancini, F.; Andrisano, V.; Rampa, A. From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease. Pharmacol. Res. Perspect. 2014, 2, e00023.
28. Kasprzak, M.M.; Erxleben, A.; Ochocki, J. Properties and applications of flavonoid metal complexes. RSC Adv. 2015, 5, 45853-45877.